The Trump administration has issued a policy change that could drive up prices of certain biologic drugs, implementing a new industry-backed measure that overturns existing regulation that promoted lower prices.
from WSJ.com: US Business http://ift.tt/2u9hnqF
via IFTTT
No comments:
Post a Comment